Adaptive Biotechnologies (ADPT) Gains from Investment Securities (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Gains from Investment Securities of -$14000.0 for Q1 2026, up 86.14% sequentially from -$101000.0 in Q4 2025, and up 81.58% YoY from -$7710.1 in Q1 2025.
Adaptive Biotechnologies (ADPT) Gains from Investment Securities (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 9 years of Gains from Investment Securities data on file, last reported at -$14000.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 81.58% year-over-year to -$14000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $162000.0 (down 98.28% YoY) and the FY2025 annual result came in at $10.0 million, down 18.31% from the prior year.
- Gains from Investment Securities climbed to -$14000.0 in Q1 2026 per ADPT's latest filing, from -$101000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $14.1 million in Q2 2023, with the low at -$101000.0 in Q4 2025.
- Average Gains from Investment Securities over 5 years is $5.2 million, with a median of $1.6 million recorded in 2022.
- Year-over-year, Gains from Investment Securities soared 10919.42% in 2024 and sank 128.61% in 2025.
- Adaptive Biotechnologies' Gains from Investment Securities stood at $7.6 million in 2022, then slumped by 79.35% to $1.6 million in 2023, then sank by 77.44% to $353000.0 in 2024, then sank by 128.61% to -$101000.0 in 2025, then jumped by 86.14% to -$14000.0 in 2026.
- Business Quant data shows ADPT's Gains from Investment Securities at -$14000.0 in Q1 2026, -$101000.0 in Q4 2025, and $11.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,109.00 |
| Mar 31, 2026 | 1,109.00 |
| Dec 31, 2025 | -101,000.00 |
| Dec 31, 2025 | -101,000.00 |
| Sep 30, 2025 | 11.06 Mn |
| Sep 30, 2025 | 11.06 Mn |
| Jun 30, 2025 | 11.39 Mn |
| Jun 30, 2025 | 11.39 Mn |
| Mar 31, 2025 | -76,000.00 |
| Mar 31, 2025 | -76,000.00 |
| Dec 31, 2024 | 353,000.00 |
| Dec 31, 2024 | 353,000.00 |
| Sep 30, 2024 | 12.41 Mn |
| Sep 30, 2024 | 12.41 Mn |
| Jun 30, 2024 | 12.82 Mn |
| Jun 30, 2024 | 12.82 Mn |
| Mar 31, 2024 | -114,000.00 |
| Mar 31, 2024 | -114,000.00 |
| Dec 31, 2023 | 1.57 Mn |
| Dec 31, 2023 | 1.57 Mn |